cromolyn sodium has been researched along with chitosan in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
de Lima, CR; Fonseca, JL; Pereira, MR | 1 |
El-Maraghy, SA; ElMeshad, AN; Hammam, OA; Motawi, TK; Nady, OM | 1 |
Abruzzo, A; Bigucci, F; Cavallari, C; Cerchiara, T; Luppi, B; Saladini, B; Zuccheri, G | 1 |
Joyce, P; Peressin, K; Prestidge, CA; Wignall, A; Williams, DB; Wright, L | 1 |
El-Maraghy, SA; Motawi, TK; Nady, OM; Sabry, D; Senousy, MA | 1 |
5 other study(ies) available for cromolyn sodium and chitosan
Article | Year |
---|---|
Equilibrium and kinetic aspects of sodium cromoglycate adsorption on chitosan: mass uptake and surface charging considerations.
Topics: Adsorption; Chitosan; Cromolyn Sodium; Kinetics; Molecular Structure; Surface Properties | 2013 |
Cromolyn chitosan nanoparticles as a novel protective approach for colorectal cancer.
Topics: Animals; Antineoplastic Agents; beta Catenin; Chitosan; Colorectal Neoplasms; Cromolyn Sodium; Dimethylhydrazines; Drug Carriers; Drug Liberation; Lipid Peroxidation; Male; Nanoparticles; Particle Size; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Signal Transduction | 2017 |
Cromolyn-crosslinked chitosan nanoparticles for the treatment of allergic rhinitis.
Topics: Adhesiveness; Animals; Anti-Allergic Agents; Chitosan; Cromolyn Sodium; Drug Liberation; Nanoparticles; Nasal Mucosa; Permeability; Rhinitis, Allergic; Sheep | 2019 |
Chitosan nanoparticles facilitate improved intestinal permeation and oral pharmacokinetics of the mast cell stabiliser cromoglycate.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Chitosan; Cromolyn Sodium; Drug Carriers; Humans; Mast Cell Stabilizers; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley | 2022 |
Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.
Topics: Animals; Ascites; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Chitosan; Cromolyn Sodium; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Genes, p16; Heterografts; Humans; Mice; Nanoparticles; RNA, Neoplasm | 2022 |